KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Evolent Health (EVH) Net Margin (2016 - 2025)

Evolent Health has reported Net Margin over the past 11 years, most recently at 91.55% for Q4 2025.

  • Quarterly results put Net Margin at 91.55% for Q4 2025, down 8682.0% from a year ago — trailing twelve months through Dec 2025 was 30.88% (down 2722.0% YoY), and the annual figure for FY2025 was 30.88%, down 2722.0%.
  • Net Margin for Q4 2025 was 91.55% at Evolent Health, down from 5.62% in the prior quarter.
  • Over the last five years, Net Margin for EVH hit a ceiling of 0.6% in Q3 2022 and a floor of 91.55% in Q4 2025.
  • Median Net Margin over the past 5 years was 4.88% (2024), compared with a mean of 9.48%.
  • Biggest five-year swings in Net Margin: surged 8956bps in 2021 and later tumbled -8682bps in 2025.
  • Evolent Health's Net Margin stood at 2.27% in 2021, then tumbled by -31bps to 2.97% in 2022, then plummeted by -151bps to 7.44% in 2023, then skyrocketed by 36bps to 4.74% in 2024, then crashed by -1833bps to 91.55% in 2025.
  • The last three reported values for Net Margin were 91.55% (Q4 2025), 5.62% (Q3 2025), and 11.5% (Q2 2025) per Business Quant data.